WHO updates recommendations for contraceptive eligibility for women at high risk of HIV

31 August, 2019

Dear Colleagues,

WHO has released New Recommendations for Contraception for Women at High Risk of HIV [https://apps.who.int/iris/bitstream/handle/10665/326653/9789241550574-en.... Key messages, the WHO Press Release, and a link to a Webinar outlining the Guideline Review Process and Recommendations can be accessed from the links below.

Key Messages:

- A woman’s risk of HIV does not restrict her contraceptive choice

-- Women at a high risk of HIV infection are eligible to use all progestogen-only contraceptive methods without restriction (MEC Category 1), including progestogen-only pill (POPs), intramuscular and subcutaneous depot medroxyprogesterone acetate (DMPA-IM and DMPA-SC), norethisterone enanthate (NET-EN), levonorgestrel (LNG) implants and etonogestrel (ETG) implants.

-- Women at a high risk of HIV infection are eligible to use copper-bearing intrauterine devices (Cu-IUDs) and LNGIUDs without restriction (MEC Category 1). In considering the use of IUDs, many women at a high risk of HIV are also at risk of other sexually transmitted infections (STIs); for these women, providers should refer to the MEC recommendation on women at an increased risk of STIs, and the Selected practice recommendations for contraceptive use: third edition [https://www.who.int/reproductivehealth/publications/family_planning/SPR-... on STI screening before IUD insertion.

-- Women at a high risk of HIV infection are eligible to use all combined hormonal contraceptive methods without restriction (MEC Category 1), including combined oral contraceptives (COCs), combined injectable contraceptives (CICs), combined contraceptive patches and combined vaginal rings.

Efforts to expand contraceptive method options and ensure full and equitable access to family planning services must continue.

A renewed emphasis on HIV/STI testing and prevention services is urgently needed, including the integration of family planning and HIV/STI services as appropriate, along with sexual and reproductive health packages.

*Note: IBP and the SRHR Linkages Group will be hosting a webinar on Thursday September 12th at 9amEST/3pmCEST on Accelerating SRHR and HIV Service Delivery Integration. Register here: https://register.gotowebinar.com/register/8557714903977555212

WHO Press Release

https://www.who.int/news-room/detail/29-08-2019-who-revises-recommendati...

For more information, visit the WHO Website: www.who.int/reproductivehealth

WHO Recommendations on Contraceptive Methods for Women at High Risk of HIV

Download Here: https://www.who.int/reproductivehealth/contraceptive-eligibility-women-a...

Webinar: WHO Recommendations on the use of contraceptive methods by women at high risk of HIV

View Here: https://www.youtube.com/watch?v=70t75qXGm-0

IBP/IAWG SRHR Webinar September 12th 9amEST/3pmCEST: Register Here https://register.gotowebinar.com/register/8557714903977555212

Nandita Thatte, DrPH

Implementing Best Practices (IBP) Initiative

Department of Reproductive Health and Research

World Health Organization

Geneva, Switzerland

Email: thatten@who.int

www.who.int/reproductivehealth

HIFA profile: Nandita Thatte is a Technical Officer at the World Health Organization, Geneva, Switzerland. She is a member of the HIFA working group on Family Planning.

www.hifa.org/projects/family-planning www.hifa.org/support/members/nandita